A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The Phase 1 trial will target senescent T cells, which accumulate as we age or fight chronic…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.